Split-image illustration contrasting swift private clinic access to Mounjaro for the wealthy versus long NHS queues for obesity patients in the UK.
Billede genereret af AI

UK researchers warn NHS rollout of Mounjaro could widen inequalities in obesity care

Rapporteret af AI Billede genereret af AI Faktatjekket

UK specialists say strict early access rules for the weight-loss drug tirzepatide (Mounjaro) risk creating a “two-tier” obesity treatment system, with people who can pay privately getting faster access than those relying on the National Health Service.

A Cl0p ransomware attack has affected patient and staff data at Barts Health NHS. The breach occurred through the organization's Oracle E-Business Suite. Details emerged in a recent report on the incident.

Dette websted bruger cookies

Vi bruger cookies til analyse for at forbedre vores side. Læs vores privatlivspolitik for mere information.
Afvis